Blog
RSS FeedPosted by Michael Wonder on 20 Jan 2020
Fees and charges proposal 2020-21
20 January 2020 - The TGA is undertaking a consultation through its website to seek stakeholder's views on TGA’s proposed fees ...
Posted by Michael Wonder on 27 Nov 2017
Merck invited to submit a CDF proposal for Merkel cell cancer drug
27 November 2017 - NICE has asked Merck to submit a Cancer Drugs Fund proposal for an immunotherapy called avelumab. ...
Posted by Michael Wonder on 28 Jun 2017
J&J, Medtronic push back against TGA priority review proposal
21 June 2017 - Johnson & Johnson and Medtronic are pushing back against the Australian TGA’s proposed priority review pathway ...
Posted by Michael Wonder on 19 Jun 2017
Accelerated assessment of medical devices - priority review pathway
19 June 2017 - The TGA sought comments from interested parties on the consultation paper for accelerated assessment of medical devices ...
Posted by Michael Wonder on 09 Mar 2016
European scheme to develop drugs for diseases with no treatment launched
8 March 2016 - Unlike the UK’s Early Access to Medicines scheme, PRIME does not shorten the authorisation procedure. ...
Posted by Michael Wonder on 27 Oct 2015
Public consultation starts on PRIME - a new scheme to optimise development of priority medicines and facilitate patients’ access
26 October 2015 - PRIME aims to strengthen support to medicines that have the potential to benefit patients who presently have ...
Posted by Michael Wonder on 17 Sep 2015
Australia eyes biotechnology start-ups to remedy resources slump
17 September 2015 - Australia is taking a page from Silicon Valley’s playbook as it seeks to reinvigorate its resource-dependent economy ...
Posted by Michael Wonder on 11 Sep 2015
Merck intends to submit cladribine tablets to treat multiple sclerosis for registration in Europe
11 September 2015 -Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials ...